234 related articles for article (PubMed ID: 36629265)
1. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.
Thurber KM; Otto AO; Stricker SL
Am J Health Syst Pharm; 2023 Apr; 80(8):487-494. PubMed ID: 36629265
[TBL] [Abstract][Full Text] [Related]
2. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
3. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
Targownik LE; Fisher DA; Saini SD
Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitors: Review of Emerging Concerns.
Nehra AK; Alexander JA; Loftus CG; Nehra V
Mayo Clin Proc; 2018 Feb; 93(2):240-246. PubMed ID: 29406201
[TBL] [Abstract][Full Text] [Related]
6. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.
Tjon JA; Pe M; Soscia J; Mahant S
Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734
[TBL] [Abstract][Full Text] [Related]
8. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?
Ben-Eltriki M; Chhabra M; Cassels A; Wright JM
Curr Drug Saf; 2024; 19(2):244-247. PubMed ID: 37496243
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
[TBL] [Abstract][Full Text] [Related]
10. Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.
Rababa M; Rababa'h A
BMC Geriatr; 2020 Oct; 20(1):431. PubMed ID: 33121444
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors for chronic obstructive pulmonary disease.
Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
[TBL] [Abstract][Full Text] [Related]
12. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
[TBL] [Abstract][Full Text] [Related]
13. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
Dharmarajan TS
J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
[TBL] [Abstract][Full Text] [Related]
14. [What is the REAL long-term risk of proton pump inhibitors?].
Ribiere S; Guillaumot MA; Barré A; Abou Ali E; Barret M; Chaussade S; Coriat R
Presse Med; 2019 May; 48(5):503-510. PubMed ID: 30926204
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
[TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review.
Edinoff AN; Wu NW; Parker K; Dudossat E; Linquest L; Flanagan CJ; Dharani A; Patel H; Willett O; Cornett EM; Kaye AM; Kaye AD
Adv Ther; 2023 Jun; 40(6):2693-2709. PubMed ID: 37140707
[TBL] [Abstract][Full Text] [Related]
18. Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.
Corsonello A; Lattanzio F; Bustacchini S; Garasto S; Cozza A; Schepisi R; Lenci F; Luciani F; Maggio MG; Ticinesi A; Butto V; Tagliaferri S; Corica F
Curr Drug Metab; 2018; 19(2):142-154. PubMed ID: 29219052
[TBL] [Abstract][Full Text] [Related]
19. Fracture risk and bone mineral density reduction associated with proton pump inhibitors.
Lau YT; Ahmed NN
Pharmacotherapy; 2012 Jan; 32(1):67-79. PubMed ID: 22392829
[TBL] [Abstract][Full Text] [Related]
20. [Emergent adverse effects of proton pump inhibitors].
Bourne C; Charpiat B; Charhon N; Bertin C; Gouraud A; Mouchoux C; Skalli S; Janoly-Dumenil A
Presse Med; 2013 Feb; 42(2):e53-62. PubMed ID: 23237784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
